Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 30 Jul 2026 for Neurocrine Biosciences INC, €200k. Read the official filing
Filing timeline
BuySaleLeslie Norwalk V
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Leslie Norwalk V: trading record in brief
Leslie Norwalk V (senior executive) discloses dealings in 8 companies, chiefly Neurocrine Biosciences Inc, Globus Medical Inc and Arvinas, Inc. In total, 30 filings cover trades dated from 1 June 2021 to 29 July 2026.
No open-market purchase appears, only 6 sales worth €1.7M. The rest of the record consists of 15 share grants and 7 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
The newest entry dates from 30 July 2026: an open-market sale of €200k, in Neurocrine Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leslie Norwalk V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
1,250 shares@ US$182.006Common StockSEC:0001533568-26-000012:0
842 shares@ US$139.43Common StockSEC:0001533568-26-000012:1
15,527 sharesCommon StockSEC:0001628280-26-045787:0
1,447 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000070:0
3,810 shares@ US$155.01340.0035% mcap50.0% of flowCommon StockSEC:0001533568-26-000003:0
2,000 shares@ US$101.1016.6% of flowClass A Common StockSEC:0001193125-26-010697:0
8,276 shares@ US$92.3536.6% of flowCommon StockSEC:0001533568-25-000007:0
4,000 shares@ US$88.8534.7% of flowClass A Common StockSEC:0001193125-25-320898:0
1,652 shares@ US$76.0423.6% of flowCommon StockSEC:0000064803-25-000064:0
16,025 shares0Common StockSEC:0001655759-25-000112:0
1,435 shares0Common StockSEC:0000914475-25-000126:0
2,077 shares@ US$60.4723.8% of flowCommon StockSEC:0001127602-25-014957:0
2,200 shares@ US$57.1025.2% of flowCommon StockSEC:0001127602-24-028008:0
1,000 shares@ US$70.0011.3% of flowClass A Common StockSEC:0000950170-24-083594:0
5,899 shares0Common StockSEC:0001655759-24-000081:0
2,100 shares0Common StockSEC:0000914475-24-000132:0
10,590 shares@ US$51.9988.7% of flowClass A Common StockSEC:0000950170-24-033817:0
8,000 shares@ US$84.9538.4% of flowCommon StockSEC:0000914475-24-000080:0
2,658 shares0Common StockSEC:0001437749-24-004597:0
2,321 sharesClass A Common StockSEC:0001209191-23-048414:0
3,095 sharesCommon Stock, par value $0.001 per shareSEC:0001209191-23-048186:0
4,121 shares0Common StockSEC:0001655759-23-000066:0
1,314 shares0Common StockSEC:0001437749-23-003976:0
1,547 shares0Common StockSEC:0001209191-22-033199:0
381.005 shares@ US$82.020.0001% mcap100.0% of flowCommon StockSEC:0001071739-22-000147:0
25 of 30 declarations
